Furthermore, we also report that PEAK1 expression levels significantly and positively correlate with EMT gene expression signatures in patient samples and ER- and/or HER2-positive breast cancer cell populations (S1 Fig). The gene discussed is ERBB2; the disease is breast carcinoma.